Stuart J McDonald1,2, William T O'Brien3, Georgia F Symons3, Zhibin Chen3,4,5, Jesse Bain3, Brendan P Major3, Daniel Costello5, Glenn Yamakawa3, Mujun Sun3, Rhys D Brady3,5, Biswadev Mitra6,7,8, Richelle Mychasiuk3, Terence J O'Brien3,5, Sandy R Shultz3,5. 1. Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia. stuart.mcdonald@monash.edu. 2. Department of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC, Australia. stuart.mcdonald@monash.edu. 3. Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia. 4. Clinical Epidemiology, Monash University, Melbourne, VIC, Australia. 5. Department of Medicine, The University of Melbourne, Parkville, VIC, Australia. 6. National Trauma Research Institute, Melbourne, VIC, Australia. 7. Emergency and Trauma Centre, The Alfred Hospital, Melbourne, VIC, Australia. 8. Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Abstract
BACKGROUND: Biomarkers that can objectively guide the diagnosis of sports-related concussion, and consequent return-to-play decisions, are urgently needed. In this study, we aimed to determine the temporal profile and diagnostic ability of serum levels of neurofilament light (NfL), ubiquitin carboxy-terminal hydrolase L1 (UCHL1), glial fibrillary acidic protein (GFAP), and tau in concussed male and female Australian footballers. METHODS: Blood was collected from 28 Australian rules footballers (20 males, 8 females) at 2-, 6-, and 13-days after a diagnosed concussion for comparison to their levels at baseline (i.e. pre-season), and with 27 control players (19 males, 8 females) without a diagnosis of concussion. Serum concentrations of protein markers associated with damage to neurons (UCHL1), axons (NfL, tau), and astrocytes (GFAP) were quantified using a Simoa HD-X Analyzer. Biomarker levels for concussed players were compared over time and between sex using generalised linear mixed effect models, and diagnostic performance was assessed using area under the receiver operating characteristic curve (AUROC) analysis. RESULTS: Serum NfL was increased from baseline in male footballers at 6- and 13-days post-concussion. GFAP and tau were increased in male footballers with concussion at 2- and 13-days respectively. NfL concentrations discriminated between concussed and non-concussed male footballers at all time-points (AUROC: 2d = 0.73, 6d = 0.85, 13d = 0.79), with tau also demonstrating utility at 13d (AUROC = 0.72). No biomarker differences were observed in female footballers after concussion. CONCLUSIONS: Serum NfL may be a useful biomarker for the acute and sub-acute diagnosis of concussion in males, and could inform neurobiological recovery and return-to-play decisions. Future adequately powered studies are still needed to investigate biomarker changes in concussed females.
BACKGROUND: Biomarkers that can objectively guide the diagnosis of sports-related concussion, and consequent return-to-play decisions, are urgently needed. In this study, we aimed to determine the temporal profile and diagnostic ability of serum levels of neurofilament light (NfL), ubiquitin carboxy-terminal hydrolase L1 (UCHL1), glial fibrillary acidic protein (GFAP), and tau in concussed male and female Australian footballers. METHODS: Blood was collected from 28 Australian rules footballers (20 males, 8 females) at 2-, 6-, and 13-days after a diagnosed concussion for comparison to their levels at baseline (i.e. pre-season), and with 27 control players (19 males, 8 females) without a diagnosis of concussion. Serum concentrations of protein markers associated with damage to neurons (UCHL1), axons (NfL, tau), and astrocytes (GFAP) were quantified using a Simoa HD-X Analyzer. Biomarker levels for concussed players were compared over time and between sex using generalised linear mixed effect models, and diagnostic performance was assessed using area under the receiver operating characteristic curve (AUROC) analysis. RESULTS: Serum NfL was increased from baseline in male footballers at 6- and 13-days post-concussion. GFAP and tau were increased in male footballers with concussion at 2- and 13-days respectively. NfL concentrations discriminated between concussed and non-concussed male footballers at all time-points (AUROC: 2d = 0.73, 6d = 0.85, 13d = 0.79), with tau also demonstrating utility at 13d (AUROC = 0.72). No biomarker differences were observed in female footballers after concussion. CONCLUSIONS: Serum NfL may be a useful biomarker for the acute and sub-acute diagnosis of concussion in males, and could inform neurobiological recovery and return-to-play decisions. Future adequately powered studies are still needed to investigate biomarker changes in concussed females.
Authors: Paul McCrory; Willem Meeuwisse; Jiří Dvořák; Mark Aubry; Julian Bailes; Steven Broglio; Robert C Cantu; David Cassidy; Ruben J Echemendia; Rudy J Castellani; Gavin A Davis; Richard Ellenbogen; Carolyn Emery; Lars Engebretsen; Nina Feddermann-Demont; Christopher C Giza; Kevin M Guskiewicz; Stanley Herring; Grant L Iverson; Karen M Johnston; James Kissick; Jeffrey Kutcher; John J Leddy; David Maddocks; Michael Makdissi; Geoff T Manley; Michael McCrea; William P Meehan; Shinji Nagahiro; Jon Patricios; Margot Putukian; Kathryn J Schneider; Allen Sills; Charles H Tator; Michael Turner; Pieter E Vos Journal: Br J Sports Med Date: 2017-04-26 Impact factor: 13.800
Authors: Linda Papa; Michelle M Ramia; Damyan Edwards; Brian D Johnson; Semyon M Slobounov Journal: J Neurotrauma Date: 2015-01-23 Impact factor: 5.269
Authors: Michael Makdissi; Robert C Cantu; Karen M Johnston; Paul McCrory; Willem H Meeuwisse Journal: Br J Sports Med Date: 2013-04 Impact factor: 13.800
Authors: Geoff Manley; Andrew J Gardner; Kathryn J Schneider; Kevin M Guskiewicz; Julian Bailes; Robert C Cantu; Rudolph J Castellani; Michael Turner; Barry D Jordan; Christopher Randolph; Jiří Dvořák; K Alix Hayden; Charles H Tator; Paul McCrory; Grant L Iverson Journal: Br J Sports Med Date: 2017-04-28 Impact factor: 13.800
Authors: Michael McCrea; Steven P Broglio; Thomas W McAllister; Jessica Gill; Christopher C Giza; Daniel L Huber; Jaroslaw Harezlak; Kenneth L Cameron; Megan N Houston; Gerald McGinty; Jonathan C Jackson; Kevin Guskiewicz; Jason Mihalik; M Alison Brooks; Stephan Duma; Steven Rowson; Lindsay D Nelson; Paul Pasquina; Timothy B Meier; Tatiana Foroud; Barry P Katz; Andrew J Saykin; Darren E Campbell; Steven J Svoboda; Joshua Goldman; Jon DiFiori Journal: JAMA Netw Open Date: 2020-01-03
Authors: George Anis Sarkis; Tian Zhu; Zhihui Yang; Xue Li; Yuan Shi; Richard Rubenstein; Richard A Yost; Geoffrey T Manley; Kevin K Wang Journal: Biomark Med Date: 2021-10-22 Impact factor: 2.851
Authors: Linda Papa; Alexa E Walter; James R Wilkes; Hunter S Clonts; Brian Johnson; Semyon M Slobounov Journal: J Neurotrauma Date: 2022-09-01 Impact factor: 4.869
Authors: Harm Jan van der Horn; Koen Visser; Johan Bijzet; Pieter Vos; Joukje van der Naalt; Bram Jacobs Journal: Front Neurol Date: 2022-05-18 Impact factor: 4.086
Authors: Ker Rui Wong; William T O'Brien; Mujun Sun; Glenn Yamakawa; Terence J O'Brien; Richelle Mychasiuk; Sandy R Shultz; Stuart J McDonald; Rhys D Brady Journal: Biomark Insights Date: 2021-10-26
Authors: Sandy R Shultz; Caroline J Taylor; Riemke Aggio-Bruce; William T O'Brien; Mujun Sun; Adrian V Cioanca; George Neocleous; Georgia F Symons; Rhys D Brady; Anandwardhan A Hardikar; Mugdha V Joglekar; Daniel M Costello; Terence J O'Brien; Riccardo Natoli; Stuart J McDonald Journal: Biomark Insights Date: 2022-02-28
Authors: Brian D Stemper; Alok Shah; Rachel Chiariello; Cassandra McCarthy; Kristin Jessen; Bailey Sarka; Jack Seifert; Matthew D Budde; Kevin Wang; Christopher M Olsen; Michael McCrea Journal: Front Behav Neurosci Date: 2022-03-09 Impact factor: 3.558
Authors: Rebecca Halbgebauer; Steffen Halbgebauer; Patrick Oeckl; Petra Steinacker; Eberhard Weihe; Martin K-H Schafer; Francesco Roselli; Florian Gebhard; Markus Huber-Lang; Markus Otto Journal: Int J Mol Sci Date: 2022-08-25 Impact factor: 6.208